From Jiji
December 26 2024
TOKYO – Hong Kong-based activist investor Oasis Management Co. has increased its equity stake in Japan’s Kobayashi Pharmaceutical Co., rocked by a high-profile health hazard scandal over its supplements containing “beni koji” red fermented rice, according to a share transaction report.
In the report filed with the Kanto Local Finance Bureau on Wednesday, Oasis Management said its stake in Kobayashi Pharmaceutical climbed to 10.1 pct from 7.5 pct, coming close to the ownership ratio of the Japanese company’s largest shareholder.

0 comments on “Hong Kong Fund Ups Stake in Kobayashi Pharma”